This nanoplatform halts the tumor cell cycle by inhibiting cyclin-dependent kinase 4, but also uses PDT, activated by laser irradiation, to facilitate the release of tumor antigens and attract dendritic cells [38]. This evidence concerns the gene CDK4 and neoplasm.